Abhilasha Pharma
CEP Certificates (EDQM COS List)

Abhilasha Pharma

CEP Database

Certificates of Suitability to the European Pharmacopoeia (CEP), issued by the EDQM.

Chemical India
  • Total Records 1
  • Latest End Date -
  • Data Source EDQM
  • Last Updated 2025-02-11
Company Overview

Company

Abhilasha Pharma

Country

India

Company Snapshot

Abhilasha Pharma

Plot No. 1408-1409.G.I.D.C Ankleshwar-393 002

India

www.abhilashapharma.com/ info@abhilashapharma.com View on Map
CEP Records Timeline (1 record)
2025
11 Feb
Chemical Valid

Product

Metformin Hydrochloride

Substance

ABHILASHA PHARMA PRIVATE LIMITED Ankleshwar IN

Certificate No.

CEP 2024-016 - Rev 00

Substance No.

931

Issue Date

2025-02-11

End Date

-

Country

India

Identifiers

Certificate No.: CEP 2024-016 - Rev 00
Substance No.: 931

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    1 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
Official Source

All data is sourced from the official EDQM CEP database (Certification of Suitability to the European Pharmacopoeia).

Visit EDQM
Record Details Preview

Click "View Details" on any record above to expand full details inline.

Country

India

Identifiers

Certificate No.: CEP 2024-016 - Rev 00
Substance No.: 931

100% Official Data

Directly from the EDQM CEP database

Regular Updates

Data updated regularly from official sources

Trusted by Professionals

100K+ pharma professionals worldwide

Secure & Reliable

Enterprise-grade security and data protection

CEP data is obtained from the official EDQM (European Directorate for the Quality of Medicines) database.

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.